transcription factor SCIP/Tst-1 is expressed at a high level; when oligodendrocyte differentiation is initiated by withdrawing the growth factors,. SCIP/Tst-1 mRNA ...
Growth factors and transcription factors in oligodendrocyte development
ELLEN J. COLLARINI1, NIGEL PRINGLE1, HARDEEP MUDHAR1, GEORGINA STEVENS1, RAINER KUHN2, EDWIN S. MONUKI2, GREG LEMKE2 and WILLIAM D. RICHARDSON1 1Department of Biology (Medawar Building), University College London, Gower Street, London WC1E 6BT, UK and 2The Salk Institute, 10010 N Torrey Pines Road, La Jolla, CA 92037, USA
Summary 0-2A progenitor cells, the precursors of oligodendro cytes in the central nervous system (CNS), probably originate in the subventricular germinal zones of the developing CNS, and subsequently migrate away from there to populate the rest of the CNS with oligodendrocytes. We are trying to understand how the 0-2A progenitor cells interact with their chang ing environment as they migrate, and how this influences each stage of their development into mature, myelinating oligodendrocytes. In this article we summarize evidence that platelet-derived growth factor (PDGF) is important for stimulating 0-2A progenitor cell proliferation in vivo, and describe our efforts to map the distribution of PDGF and its receptors in the developing rat CNS by in situ hybridization and immunohistochemistry. These studies suggest that, in the CNS, PDGF a-receptor subunits may be restricted to 0-2A lineage cells that have started to migrate away from the subventricu lar zones towards their final destinations. Many neurons express the A and/or B chains of PDGF, and astrocytes express the A chain, but it is not yet clear which of these cell types might be the major source of PDGF for 0-2A lineage cells in vivo. 0-2A progenitor cells can be purified and maintained in a prolifer ating state in vitro by culturing in the presence of PDGF and bFGF. Under these conditions, the POU transcription factor SCIP/Tst-1 is expressed at a high level; when oligodendrocyte differentiation is initiated by withdrawing the growth factors, SCIP/Tst-1 mRNA is rapidly down-regulated, fol lowed by a decline in SCIP/Tst-1 protein and sequential activation of myelin-specific genes. These observations suggest that SCIP/Tst-1 may be mecha nistically involved in the transition from prolifer ation to differentiation in the 0-2A lineage. By in situ hybridization, SCIP/Tst-1 appears also to be ex pressed in developing neurons, so perhaps it fulfils a similar function in several different cell lineages in the CNS. Key words: PDGF, PDGF receptors, bFGF, SCIP/Tst-1, in situ hybridization, CNS, development.
Introduction Oligodendrocytes, the myelinating cells of the central nervous system (CNS), arise during development from glial progenitor cells known as 0-2A progenitors (Raff et Journal o f Cell Science, Supplement 15, 117-123 (1991) Printed in Great Britain © The Company o f Biologists Limited 1991
al. 1983). In vivo, the time course of oligodendrocyte production is precisely controlled. In the embryonic rat optic nerve, 0-2A progenitors proliferate and do not differentiate; then, starting on the day of birth, some 0-2 A progenitors stop dividing and differentiate into oligoden drocytes while the others continue to divide. Proliferation and oligodendrocyte differentiation continue together in the nerve for several weeks after birth (Miller et al. 1985). However, when embryonic or postnatal optic nerve cells are dissociated and cultured in medium containing low concentrations (0.5 %) of fetal calf serum (FCS), nearly all the 0-2A progenitors stop dividing straightaway and differentiate prematurely into oligodendrocytes (Raff et al. 1983; Raff et al. 1985). Thus, there must be environmental signals present in vivo, but missing in vitro, that are required to keep 0-2A progenitors dividing and delay the onset of oligodendrocyte differentiation. We are trying to identify these environmental factors and understand how they regulate the timing of oligodendrocyte differentiation during development. Platelet-derived growth factor (PDGF), in concert with other polypeptide growth factors, probably plays an important role in this process (reviewed by Richardson et al. 1990; see below). The earliest committed 0-2A lineage cells probably originate in the germinal zones around the ventricles (subventricular zones) and subsequently migrate away from there, maturing as they go, to populate the rest of the CNS with oligodendrocytes (Small et al. 1987; Levine and Goldman, 1988a,b; Reynolds and Wilkin, 1988). To identify environmental factors that might influence the step-wise development of 0-2A lineage cells in vivo and relate this to studies in vitro, we need to establish what polypeptide growth factors are available, and which of these the 0-2A progenitors can respond to, at each stage of their progress from immature neuroepithelial cell to mature oligodendrocyte'. With this aim in mind, we have started to map the distribution of PDGF and its receptors in the developing CNS by in situ hybridization and immunohistochemistry; our early progress and con clusions are summarized below.
PDGF, PDGF receptors and oligodendrocyte development There is now strong evidence that platelet-derived growth factor (PDGF) plays an important role in controlling the proliferation and differentiation of 0-2A progenitor cells during development. 0-2A progenitor cells freshly isolated from newborn rat optic nerves possess cell-surface recep tors for PDGF (Hart et al. 1989a; McKinnon et al. 1990), and PDGF is a potent mitogen for 0-2A progenitors in 117
vitro (Noble et al. 1988; Richardson et al. 1988). Further more, PDGF can recreate the normal timing of oligoden drocyte development in vitro (Raff et al. 1988). For example, if optic nerve cells from E17 rats are cultured in chemically defined medium containing PDGF, the 0 -2 A progenitors continue to divide for some time, and oligodendrocytes do not appear until the fourth day in culture, corresponding to the day of birth in vivo (E21). If E18 optic nerve cells are cultured in the same way, the first oligodendrocytes appear on the third day in vitro, and so on. As PDGF mRNA (Richardson et al. 1988; Pringle et al. 1989) and protein (H. Mudhar and W. Richardson, unpublished) is present in the perinatal brain and optic nerve, and PDGF-like mitogenic activity can be detected in extracts of optic nerves (Raff et al. 1988), it seems likely that PDGF may be important for normal development of the 0 -2 A lineage in vivo. PDGF is a disulfide-linked dimer of A and B chains, with the structure AA, AB or BB, depending on its source (for a review of PDGF, see Heldin and Westermark, 1989). For example, PDGF from human platelets is a mixture of all three dimeric isoforms, of which PDGF-AB is the major species, while some human tumor cell lines synthesize mainly PDGF-AA. PDGF elicits its biological effects by binding to transmembrane receptors with extracellular ligand-binding domains and intracellular tyrosine kinase domains. The unoccupied receptors are monomeric and inactive, but PDGF-binding induces dimerization and activates their tyrosine kinase activity. There are two types of PDGF receptor subunits with different ligand specificities: the «--receptor subunit (PDGF-aR) binds both A and B chains of PDGF, while the /3-receptor subunit (PDGF-/®) binds only B chains. Thus, the response of a cell to PDGF depends on the relative numbers of a- and fireceptors that it expresses as well as the PDGF isoform(s) that it encounters (see Fig. 1). 0 -2 A progenitor cells express predominantly PDGF-aR (Hart et al. 1989a; McKinnon et al. 1990), and consequently respond to all three dimeric isoforms of PDGF, although PDGF-AA is effective at lower concentrations than PDGF-BB because PDGF-aR has higher affinity for PDGF A chains than for B chains (Heldin et al. 1988). Consistent with this, we could detect mRNA encoding the PDGF A chain, but not the B chain, in the rat optic nerve (Pringle et al. 1989), suggesting that PDGF-AA might be the predominant PDGF isoform in the nerve. If PDGF is responsible for stimulating 0 -2 A progenitor proliferation during development, what causes the 0 -2 A progenitors eventually to stop dividing and differentiate into oligodendrocytes, and what dictates the timing of this decision? An 0 -2 A progenitor cell differentiates into an oligodendrocyte when it is cultured on its own in a microwell in defined medium (Temple and Raff, 1985), so oligodendrocyte differentiation seems to proceed by default when an 0 -2 A progenitor is deprived of PDGF and other exogenous signals. It is unlikely, however, that oligodendrocyte differentiation is triggered in vivo by PDGF withdrawal. First, PDGF A chain mRNA is present in the brain and optic nerve from before birth into adulthood (Richardson et al. 1988; Pringle et al. 1989), suggesting that PDGF may be continuously available throughout life. Second, 0 -2 A progenitors in optic nerve cell cultures do not proliferate indefinitely in vitro; they eventually stop dividing and differentiate into oligoden drocytes, no matter how much or how often PDGF is added to the culture medium (Raff et al. 1988). Moreover, in these cultures, dividing and differentiating 0 -2 A progenitors
118
E. J. Collarini et al.
PDGF and its receptors
a
A l-fB i a;
IBS—fBl
a;
a:
mm w a
a
a
Fig. 1. PDGF and its receptors. PDGF is a dimer of A and B chains, with the structure AA, BB or AB. PDGF œ-receptor subunits (PDGF-aR) can bind both PDGF A and B chains, while PDGF /5-receptor subunits (PDGF-/3R) can bind only PDGF B chains. Consequently, PDGF-AA can cross-link and activate only PDGF-aR, while PDGF-BB can activate both PDGF-aR and PDGF-/JR. According to this simple scheme, PDGF-AB should be able to cross-link two A chains, or one A and one B chain; therefore, PDGF-AB might be able to act as a receptor antagonist for cells with only PDGF-/2R, since it should be able to bind to, but not dimerize, PDGF-/5R (Heldin and Westermark, 1989). Recently, however, evidence has been presented that PDGF-AB can activate cells with only PDGF-/ÎR (Drozdoff and Pledger, 1991).
coexist in the same dish. This suggests that the decision to differentiate is cell-autonomous and does not depend on timed signals from other cells. Thus, in order to under stand how oligodendrocyte differentiation is timed, we need to know why proliferating 0 -2 A progenitor cells eventually lose their ability to divide in response to PDGF. In principle, this loss of responsiveness to PDGF could be caused by a loss of PDGF receptors at the cell surface, a block in one of the intracellular second messenger systems that transduces the mitogenic signal, or a deficiency in part of the cell’s replication machinery. PDGF receptor loss does not seem to be the key, because newly-formed, post-mitotic oligodendrocytes seem to have numbers of PDGF receptors similar to the proliferating 0 -2 A progeni tors that gave rise to them (Hart et al. 1989a). PDGF receptors are eventually lost from maturing oligodendro cytes, but this is a consequence of differentiation, not the cause. The PDGF receptors on newly-formed oligodendro cytes are functional, and linked into at least part of the signal transduction apparatus, because PDGF stimulation of young oligodendrocytes in vitro leads to elevation of cytosolic Ca2+ (Hart et al. 19896), and activation of the
proto-oncogene products c-Jun and c-Fos in the nucleus (Hart et al. 1990 and unpublished data). Thus, it appears that the mitotic block that develops in an 0 -2 A progenitor cell, causing it to drop out of division and differentiate into an oligodendrocyte, lies downstream of nuclear proto oncogene activation or, alternatively, in an unidentified, parallel signalling pathway.
Regulation of the SCIP transcription factor by PDGF and FGF Progress in understanding the molecular events that initiate oligodendrocyte differentiation has been ham pered by the difficulty in obtaining 0 -2 A progenitors in sufficient numbers or purity for biochemical analysis. However, recent technical developments now allow us to to purify 0 -2 A progenitors by immunoselection (B. Barres, unpublished) and keep them proliferating in vitro with a combination of basic fibroblast growth factor (bFGF) and PDGF (Bogler et al. 1990; see below). This has enabled us to examine the expression of transcription factors that might be involved in controlling the switch between proliferation and differentiation of 0 -2 A progenitors in vitro. For example, we have found that mRNA encoding the POU transcription factor SCIP (Monuki et al. 1989), also known as Tst-1 (He et al. 1989) or Oct-6 (Suzuki et al. 1990), is highly expressed in 0 -2 A progenitors that are kept proliferating in vitro with a combination of bFGF and PDGF, but declines to background levels within 6 h after oligodendrocyte differentiation is initiated by growth factor withdrawal (E. Collarini, R. Kuhn, E. Monuki, G. Lemke and W. Richardson, unpublished data; see Fig. 2). This down-regulation of SCIP mRNA is followed by a decline in SCIP protein over the next 24 h, and the subsequent appearance of myelin-specific products (Fig. 2). SCIP was previously shown to be expressed in proliferating Schwann cells, and to be down-regulated when they start to express myelin-specific genes (Monuki et al. 1989). There is in vitro evidence that SCIP is a repressor of myelin gene expression in proliferating Schwann cells (Monuki et al. 1990; He et al. 1991), and the same may be true in proliferating 0 -2 A progenitors. It is not yet known whether a high level of SCIP is necessary or sufficient to keep 0 -2 A progenitors dividing and inhibit oligodendrocyte differentiation; there is some evidence, however, that POU transcription factors may be associ ated with cell proliferation in other systems (see Scholer, 1991 for a review).
Sources of PDGF in the CNS; neurons versus glia It has been known for some time that there is mitogenic activity for Schwann cells on the surfaces of PNS axons, although it is not known whether this activity is synthesized by the neurons themselves or deposited by other cells (see below). Nevertheless, it is an attractive idea that neurons in both the PNS and CNS might produce mitogens for the glial cells with which they physically interact. The possibility that axons might influence the development of the oligodendrocyte lineage has been tested in vivo (Privat et al. 1981; David et al. 1984). Newborn rat optic nerves, which carry axons from ganglion neurons in the retina to the brain, were transected just behind the eye, causing the axons in the
Time after removal of growth factors 0
24
48
72 h SCIP
-
fgfg?
CNP
PK Fig. 2. SCIP mRNA is down-regulated, and CNP mRNA upregulated, when proliferating 0-2A progenitor cells are induced to differentiate into oligodendrocytes in vitro. Cultures of dissociated cells from rat cerebral cortex were established and grown in 10 % FCS-containing medium for one week, during which time 0-2 A lineage cells proliferated on top of a monolayer of flat, type-l-like astrocytes. The cells were dissociated with trypsin, macrophages were allowed to attach to uncoated bacterial Petri dishes for a short time and the remaining cells were subjected to immunoselection, first with an anti-GC antibody to remove unwanted oligodendrocytes, and then with antibody A2B5 to positively select 0-2A progenitors. Cells were removed from the final panning dish with trypsin, and plated in 60 mm dishes in defined medium containing PDGF-AA and bFGF (both lO n gm l” 1) and 0.5% FCS. They were maintained like this for 2 -3 days, after which time the cells were 3=97 % A2B5+. The culture medium was removed and replaced with fresh medium lacking PDGF and bFGF and, at the indicated times after growth factor withdrawal, the cells were harvested and total cellular RNA isolated. The RNA (5 ¿tg/lane) was transferred to nylon membrane and hybridized with a 32P-labelled SCIP DNA probe. The membrane was subsequently stripped and rehybridized with a CNP probe and a pyruvate kinase (PK) probe (as a control for gel loading). The figure is a composite of three autoradiographs. SCIP mRNA is high in 0-2A progenitors maintained in a proliferating state with PDGF-AA and bFGF but, in this experiment, SCIP mRNA declined to background levels within 24 h after removal of growth factors. Other experiments (not shown) demonstrated that downregulation of SCIP mRNA is complete by 6 h after growth factor withdrawal. mRNA encoding CNP, a marker of oligodendrocyte differentiation, is up-regulated following the removal of PDGF and bFGF.
nerve to degenerate rapidly. The number of oligodendro cytes and their progenitors present in the nerve stump one week later was reduced more than eight-fold compared to untransected nerves, whereas the number of type-1 astrocytes (which belong to a different cell lineage) was reduced less than two-fold (David et al. 1984). Surpris ingly, despite the large decrease in the population of oligodendrocyte lineage cells, the mitotic index of these cells did not differ significantly between transected and untransected nerves. This was interpreted to mean that 0 -2 A progenitors depend on axons, not for proliferation p er se, but rather for survival. These experiments suggested that intact axons are not obligatory for mitogenic stimulation of 0 -2 A progenitors in the optic nerve, suggesting instead that glial cells in the nerve might be the source of the mitogen(s). Support for this latter view came from the finding that cultured astrocytes from rat cerebral cortex, which resemble type-1 astrocytes PD G F and oligodendrocyte development
119
Fig. 3. PDGF A chain RNA transcripts in the developing rat CNS, revealed by in situ hybridization with a 35S-labelled RNA probe. Panel a, a section through a PO rat eye and optic nerve. PDGF A transcripts are abundant in the retinal ganglion cell layer of the retina (arrow) and in the optic nerve (asterix). Part of the nasal epithelium is also visible (lower left); the olfactory neurons also appear positive for PDGF A chain. Panel b, a horizontal section through the hippocampal region of a P5 rat brain. PDGF A is strongly expressed in hippocampal neurons, and in what appear to be neurons throughout the rest of the forebrain. Bars, 0.5 mm.
in optic nerve cell cultures, secrete a mitogen for 0-2A progenitors (Noble and Murray, 1984). This astrocytederived mitogen was subsequently shown to be a form of PDGF, possibly PDGF-AA (Richardson et al. 1988; Pringle et al. 1989). In support of a glial origin for PDGF in the optic nerve, we have recently been able to demonstrate immunostaining of glial processes in postnatal mouse and rat optic nerves, with antisera raised against the mouse PDGF A chain (H. Mudhar and W. Richardson, unpub lished). Recently it was reported that many neurons in the CNS and PNS also synthesize PDGF A and/or B chains (Yeh et al. 1991; Sasahara et al. 1991; see Fig. 3), so we should not neglect the possibility that neurons might also be an important source of PDGF (or other growth factors) for 0 -2 A progenitors in the developing CNS. There is some experimental evidence in support of this idea; 0 -2 A progenitor cells from developing rat cerebellum or optic nerve are stimulated to divide in vitro in medium conditioned by cultures of young cerebellar interneurons, and about half of this mitogenic activity can be neutralized by antibodies against PDGF (Levine, 1989). Retinal ganglion neurons contain mRNA encoding the PDGF A chain, and immunostain with anti-PDGF sera (H. Mudhar and W. Richardson, unpublished; Fig. 3), so these neurons could conceivably supply PDGF to the optic nerve, although this would probably require that PDGF be anterogradely transported along, and secreted from, the axons of retinal ganglion neurons. It remains to be seen
120
E. J. Collarini et al.
whether this can occur. It may be that neuron-derived PDGF is not involved in neuron—glial cell interactions, but instead has some autocrine function or mediates interactions between neurons and their targets. There is a recent report that many neurons in the developing rat brain possess PDGF-/3R, and that PDGF-BB enhances survival and neurite outgrowth of cultured cerebellar neurons (Smits et al. 1991).
Distribution of cells expressing PDGF-«R and SCIP in the developing CNS For a proper understanding of oligodendrocyte develop ment in vivo, we need to know the locations of the germinal zones where the first committed precursor cells arise and the routes along which they migrate. We also need to know the sequence of maturation events and where these occur, in order to determine what influence the local environment might exert at each stage of development of the 0 -2 A progenitor cells. Therefore, studies of 0 -2 A lineage development in situ are called for. There are several specific markers for the later stages of oligodendrocyte differentiation, such as (in order of appearance) the 0 4 antigen (Sommer and Schachner, 1981), galactocerebroside (Raff et al. 1978), 2',3'-cyclic nucleotide 3 '-phosphodiesterase (Trapp et al. 1988), and the myelin structural proteins (Dubois-Dalcq et al. 1986). However, there are no reliable markers for the earlier
Fig. 4. In situ hybridization of coronal sections through the developing rat forebrain, with 35S-labelled RNA probes for PDGF-aR (a, c) or SCIP (b, d). In the anterior forebrain at E18 (a), individual PDGF-aR+ cells can be recognized, and these are fairly uniformly distributed. Some PDGF-aR+ cells can be seen in the subventricular zone beneath, and lateral to, the lateral ventricles. However, there are very few PDGF-aR+ cells in the cerebral cortex at this age, and these are restricted mainly to the subcortical white matter. By PO, PDGF-aR+ cells are more numerous and are found in all regions of the cortex (c). (c shows a more posterior section, including the hippocampal formation, but the same is true throughout the forebrain). The pattern of SCIP hybridization (b, d) is quite different. At E18, SCIP+ cells are close-packed, so that individual cells cannot be distinguished. SCIP+ cells are found in the subventricular zones above and beneath the lateral ventricles, in the developing cortical plate, in the thalamus and in distinct bodies, presumably neuronal nuclei, such as that visible to the lower left of panel b. (This nucleus does not appear bilaterally because the section is not perfectly coronal.) At PO, the zone of SCIP+ cells in the subventricular zones has disappeared and the signal is confined to a broad band of cells above the lateral ventricles, corresponding roughly to the cortical plate (d). The SCIP probe is derived from the 3' end of the mRNA, including the untranslated region; it does not contain any part of the POU domain and does not cross-hybridize with other members of the POU family. Bars, 0.5 mm.
progenitor cells, because the antibodies that are often used to identify these cells in vitro, such as monoclonal A2B5 (Eisenbarth et al. 1979) and antibodies against ganglioside Gd3 (Goldman et al. 1984), also label some immature or mature neurons in tissue sections. There is therefore a pressing need for additional 0 -2 A lineage markers. We wondered whether PDGF-aR might be restricted to 0 -2 A lineage cells in the CNS, because these cells seem to comprise the vast majority of PDGF-aR+ cells in the rat optic nerve (Hart et al. 1989a). Therefore, we performed in situ hybridization experiments on sections of rat CNS, using a probe corresponding to the extracellular domain of the rat PDGF-aR. The results we obtained (N. Pringle, H. Mudhar, E. Collarini and W. Richardson, in prep aration) suggest to us that expression of PDGF-aR may indeed be restricted to the 0 -2 A lineage. The key observations are as follows. (1) PDGF-aR+ cells are
present in the optic nerve, which contains glial cells but no neurons, and these first appear at the chiasmal end of the nerve, spreading up to the retinal end in the first few days after birth just as 0 -2 A progenitor cells do (Small et al. 1987). (2) In the cerebellum, PDGF-aR+ cells first appear in small numbers around the day of birth and increase rapidly during the next few days, becoming increasingly localized to the foliar white matter tracts. In the adult, some PDGF-aR+ cells remain, mainly in the molecular layer. This fits the pattern described for GD3+ cells (putative 0 -2 A progenitors) in the developing cerebellum (Reynolds and Wilkin, 1988). (3) The spatio-temporal distribution of PDGF-oR+ cells in the cerebral cortex is again suggestive of 0 -2 A lineage cells. PDGF-aR+ first appear at the lateral and medial aspects of the subcortical white matter at about E18, and spread into all parts of the cortex by the day of birth (see Fig. 4). They continue to PDG F and oligodendrocyte development
121
increase in number until at least P10, especially in the developing subcortical white matter and corpus callosum, before declining again in the adult. This is similar to the behaviour of a class of presumptive 0-2A lineage cells described by Levine and Goldman (1988a), who studied oligodendrocyte development in the rat forebrain using antibodies against GD3 and carbonic anhydrase (CA). In contrast, most cortical neurons are formed before birth. Moreover, cortical neurons in the postnatal cortex are arranged in a series of discrete lamellae parallel to the pial surface, whereas PDGF-aR+ cells never show any signs of stratification, reinforcing the view that PDGF-aft is expressed on glial cells, not neurons. (4) The PDGF-aR hybridization signal is invariably associated with cells that possess small, round, densely-staining nuclei that are characteristic of glial cells. Conversely, where neurons can be unambiguously identified by virtue of their position and/or nuclear morphology (e.g. retinal ganglion neurons, cerebellar Purkinje neurons, hippocampal neurons), these cells are always negative for PDGF-aR. (5) 125I-PDGF binding studies in vitro indicate that neither cortical astrocytes nor microglia possess PDGF-aR (N. Pringle and W. Richardson, unpublished). If it is true that PDGF-aR is restricted to the 0-2A lineage, then what might we deduce about the develop ment of the 0-2A lineage from our in situ studies? We first see small numbers of PDGF-aR+ cells in the anterior forebrain at E14-E16. These cells first appear outside the subventicular germinal zones, suggesting that PDGF-aR is not expressed by the earliest committed 0-2A lineage cells but is up-regulated after, or shortly before they leave the germinal zones and migrate away towards their final destinations. We also considered the possibility that SCIP might specifically mark early stages of the 0-2A lineage in the CNS, since SCIP is expressed highly in proliferating 0-2A progenitors in vitro, but is strongly down-regulated when these cells are induced to differentiate by withdrawing growth factors (see above). However, in situ hybridization of developing rat CNS tissue (Fig. 4) gives no indication that SCIP is restricted to the 0-2A lineage; on the contrary, SCIP seems to be expressed in many developing neurons and even some mature neurons. For example, SCIP is expressed in a broad band of cells in the developing retina at E16 (not shown); these cells cannot belong to the 0-2A lineage because the rat retina is unmyelinated. In the anterior forebrain, SCIP mRNA is present at E16 in a broad band of cells in the subventricular zones inferior and lateral to the lateral ventricles. With increasing age, the zone of SCIP expression expands into the subventricular zone superior to the ventricles (Fig. 4), and then moves outwards towards the pial surface. By PO, the zone of SCIP expression lies just beneath the pial surface, superior to the developing subcortical white matter (see Fig. 4). This pattern of expression suggests that SCIP is expressed in a population of migrating neuronal progenitors in the cortex. By P10, SCIP mRNA is no longer detected in the cortex, but a strong signal appears in hippocampal neurons in regions CA1 and CA2. An intense SCIP signal is also observed at P5 in the trigeminal nerve, up to but not beyond the point where it enters the CNS. This presum ably represents the point where Schwann cells give way to oligodendrocytes. Surprisingly, we have been unable to detect SCIP+ cells in the P5 optic nerve, even though SCIP mRNA can be detected in the nerve at this age on Northern blots (Monuki et al. 1989). We conclude that several, perhaps many cell lineages in the PNS and CNS 122
E. J. Collarini et al.
express SCIP at some point in their development, perhaps associated with the transition from proliferation to differentiation. 0-2A progenitors presumably do express SCIP in vivo but at a level that is below the detection limit of our in situ procedure, at least in outlying regions of the CNS such as the optic nerve. Clearly, SCIP is not a useful marker for the 0-2A lineage in situ.
What is the role of FGF in 0-2A lineage development? FGF is reported to be mitogenic for 0-2A lineage cells in culture (Eccleston and Silberberg, 1985; Saneto and deVellis, 1985; McKinnon et al. 1990), although there is at least one other report that contradicts this (Hunter and Bottenstein, 1990). This disagreement may result from differences in the purity and source of the 0-2A progenitor cells and/or the particular preparation of FGF. Recently, it was found that the combination of bFGF and PDGF has a striking cooperative effect, stimulating prolonged pro liferation of 0-2A progenitors in the apparent absence of oligodendrocyte differentiation (Bogler et al. 1990). bFGF is present in the developing and mature CNS (Gospodarowicz, 1984; Gonzalez et al. 1990); by immunohistochemistry it appears to be present in the cell bodies of neurons (Janet et al. 1988). However, it is not known whether bFGF can be released from neurons, or any living cell, since its polypeptide precursor lacks a recognizable signal for entry into the constitutive secretory pathway. In any event, it seems unlikely that bFGF and PDGF act together on 0-2A progenitors in the postnatal optic nerve, or other developing white matter tracts, otherwise oligodendrocyte differentiation would presumably be inhibited. Perhaps bFGF is released only from dying cells as a response to CNS injury. Alternatively, FGF may be released from living cells by an unconventional mechan ism, but its biological effects restricted to a compartment(s) of the CNS where oligodendrocytes are not required. For example, receptors for bFGF (bFGF-R) might normally be expressed on 0-2A lineage cells only at an early stage in their development, perhaps on a population of self-renewing cells near the ventricles whose function is to generate a steady stream of migrating 0-2A progenitors or pre-progenitors. The migrating cells might normally lose bFGF-R as they move away from the subventricular layer, perhaps gaining PDGF-arR in their place. This hypothesis would fit with the observations that cells expressing bFGF-R are found predominantly in the subventricular zones of developing rat and chicken brain (Heuer et al. 1990; Wanaka, Johnson and Milbrandt, 1990), whereas putative 0-2A lineage cells expressing PDGF-aR are located mainly outside of the subventricular zone (our results, see above). To explain why 0-2A progenitors from the optic nerve respond to bFGF in vitro, we would also have to speculate that bFGF-R is inappro priately up-regulated when the cells are dissociated and placed in culture. More needs to be learned about the FGF receptors on 0-2A lineage cells in vitro and in vivo, and the availability of FGF in the CNS, before this and other possibilities can be fully explored. We thank the other members of our laboratories, past and present, for their contributions to the work described and for stimulating and enjoyable interactions. The work described here was in large part supported by the Medical Research Council, the Multiple Sclerosis Society of Great Britain and Northern Ireland, and the Wellcome Trust.
References O., W r e n , D., B a r n e t t , S. C., L a n d , H . a n d N o b l e , M. (1990). Cooperation between two growth factors promotes extended self renewal and inhibits differentiation o f 0-2A progenitor cells. Proc. natn. Acad. Sci. U.S.A. 87, 6368—6372. D a v i d , S., M i l l e r , R . H., P a t e l , R. a n d R a f f , M . (1984). Effects of neonatal transection on glial cell development in the rat optic nerve: evidence that the oligodendrocyte-type 2 astrocyte cell lineage depends on axons for its survival. J. Neurocytol. 13, 961-974. D r o z d o f f , V. a n d P l e d g e r , W. J. (1991). Cellular response to plateletderived growth factor (PDGF)-AB after down-regulation of PDGF areceptors. J. biol. Chem. 266, 17165-17172. D u b o i s - D a l c q , M., B e h a r , T., H u d s o n , L . a n d L a z z a r i n i , R. A. (1986). Emergence o f three myelin proteins in oligodendrocytes cultured without neurons. J. Cell Biol. 102, 384-392. E c c l e s t o n , P. A. a n d S i l b e r b e r g , D. H. (1985). Fibroblast growth factor is a mitogen for oligodendrocytes in vitro. Dev. Brain Res. 21, 315-318. E i s e n b a r t h , G. S., W a l s h , F. S. a n d N i r e n b u r g , M. (1979). Monoclonal antibody to a plasma membrane antigen o f neurons. Proc. natn. Acad. Sci. U.S.A. 76, 4913-4917. G o l d m a n , J. E., H i r a n o , M., Y u , R. K. a n d S e y f r i e d , T. N. (1984). G d 3 ganglioside is a glycolipid characteristic o f immature neuroectodermal cells. J. Neuroimmunol. 7, 179-192. G o n z a l e z , A.-M., B u s c a g l i a , M., O n g , M. a n d B a i r d , A. (1990). Distribution o f basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes o f diverse tissues. J. Cell Biol. 110, 753-765. G o s p o d a r o w i c z , D. (1984). Brain and pituitary growth factors. In Hormonal proteins and peptides, Volume X II (ed. C.H. Li), pp. 205-230, New York: Academic Press. H a r t , I. K . , C o l l a r i n i , E. J., B o l s o v e r , S. R . , R a f f , M. C . a n d R i c h a r d s o n , W. D. (1990). Platelet-derived growth factor and its receptors in central nervous system gliogenesis. In Cellular and molecular biology o f myelination (ed. G. Jeserich, H . H . Althaus and T.V. Waehneldt), pp. 293-307. Berlin: Springer. H a r t , I. K., R i c h a r d s o n , W. D., B o l s o v e r , S. R . a n d R a f f , M. C . (19896). PDGF and intracellular signaling in the timing o f oligodendrocyte differentiation. J. Cell Biol. 109, 3411-3417. H a r t , I. K., R i c h a r d s o n , W . D., H e l d i n , C.-H., W e s t e r m a r k , B. a n d R a f f , M. C. (1989a). PDGF receptors on cells o f the oligodendrocytetype-2 astrocyte (0-2A ) cell lineage. Development 105, 595-603. H e , X., G errero , R., S im m o n s , D. M., P a r k , R. E., L in , C. R., S w a n so n , L. W. an d R osenfeld , M. G. (1991). Tst-1, a m em ber o f the POU
B ôgler,
dom ain gene fam ily, binds the prom oter o f the gene encoding the cell surface adhesion m olecule Po. Molec. cell. Biol. 11, 1739-1744.
He, X., T r e a c y , M. N., S i m m o n s , D. M., I n g r a h a m , H. A., S w a n s o n , L. W. a n d R o s e n f e l d , M. G. (1989). Expression o f a large family of POU-domain regulatory genes in mammalian brain development. Nature 340, 35-42. H e l d i n , C.-H., B à c k s t r ô m , G., Ô s t m a n , A., H a m m a c h e r , A., R ô n n s t r a n d , L., R u b i n , K., N i s t é r , M. a n d W e s t e r m a r k , B . (1988). Binding o f different dimeric forms o f PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J. 7, 1387-1393. H e l d i n , C.-H. a n d W e s t e r m a r k , B. (1989). Platelet-derived growth factor: three isoforms and two receptor types. Trends Genet. 5, 108-111. H e u e r , F. G., V o n B a r t h e l d , C. S., K i n o s h i t a , Y., E v e r s , P. C. a n d B o t h w e l l , M. (1990). Alternating phases o f FGF receptor and NGF receptor expression in the developing chicken nervous system. Neuron 5, 283-296. H u n t e r , S. F. a n d B o t t e n s t e i n , J. E. (1990). Growth factor responses of enriched bipotential glial progenitors. Dev. Brain Res. 54, 235-248. J a n e t , T., G r o t h e , C., P e t t m a n n , B., U n s i c k e r , K. a n d S e n s e n b r e n n e r , M. (1988). Immunocytochemical demonstration of fibroblast growth factor in cultured chick and rat neurons. J. Neurosci. Res. 19, 195—201. L e v i n e , J. M. (1989). Neuronal influences on glial progenitor cell development. Neuron 3, 103-113. L E v rN E , S. M. a n d G o l d m a n , J. E. (1988#). Spatial and temporal patterns o f oligodendrocyte differentiation in rat cerebrum and cerebellum. J. comp. Neurol. 277, 441-455. L e v i n e , S. M. a n d G o l d m a n , J. E. (19886). Embryonic divergence of oligodendrocyte and astrocyte lineages in developing rat cerebrum. J. Neurosci. 8, 3992-4006. M c K i n n o n , R. D ., M a t s u i , T., D u b o i s - D a l c q , M . a n d A a r o n s o n , S . A . (1990). FGF modulates the PDGF-driven pathway o f oligodendrocyte development. Neuron 5, 603-614. M i l l e r , R . H,, D a v i d , S., P a t e l , R . , A b n e y , E. R . a n d R a f f , M . (1985). A quantitative immunohistochemical study o f macroglial cell
development in the rat optic nerve: in vivo evidence for two distinct astrocyte lineages. Devi Biol. I l l , 35-41. M o n u k i , E. S ., K u h n , R . , W e i n m a s t e r , G., T r a p p , B . D . a n d L e m k e , G. (1990). Expression and activity o f the POU transcription factor SCIP. Science 249, 1300-1303. M o n u k i , E. S., W e i n m a s t e r , G., K u h n , R. a n d L e m k e , G. (1989). SCIP: a glial POU domain gene regulated by cyclic AMP. Neuron 3, 783-793. N o b l e , M . a n d M u r r a y , K . (1984). Purified astrocytes promote the in vitro division o f a bipotential glial progenitor cell. EMBO J. 3, 2243-2247. N o b l e , M . , M u r r a y , K . , S t r o o b a n t , P., W a t e r f i e l d , M . D . a n d R i d d l e , P. (1988). Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333, 560-562. P r i n g l e , N . , C o l l a r i n i , E. J., M o s l e y , M . J., H e l d i n , C . - H ., W e s t e r m a r k , B. a n d R i c h a r d s o n , W . D. (1989). PDGF A chain homodimers drive proliferation of bipotential (0-2A ) glial progenitor cells in the developing rat optic nerve. EMBO J. 8, 1049-1056. P r i v a t , A., V a l a t , J. a n d F u l c r a n d , J. (1981). Proliferation of neuroglial cell lines in the degenerating optic nerve o f young rats. J. Neuropath, exp. Neurol. 40, 46-60. R a f f , M . C . , A b n e y , E. R . a n d F o k - S e a n g , J . (1985). Reconstitution of a developmental clock in vitro: a critical role for astrocytes in the timing o f oligodendrocyte differentiation. Cell 42, 61—69. R a f f , M. C ., L i l l i e n , L. E., R i c h a r d s o n , W . D ., B u r n e , J . F. a n d N o b l e , M. (1988). Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333, 562—565. R a f f , M . C ., M i l l e r , R . H . a n d N o b l e , M . (1983). A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on the culture medium. Nature 303, 390-396. R a f f , M . C ., M i r s k y , R . , F i e l d s , K . L ., L i s a k , R . P ., D o r f m a n , S . H., S i l b e r b e r g , D . H., G r e g s o n , N . A . , L i e b o w i t z , S . a n d K e n n e d y , M . (1978). Galactocerebroside: a specific cell surface antigenic marker for oligodendrocytes in culture. Nature 274, 813-816. R e y n o l d s , R . a n d W i l k i n , G . P . (1988). Development of macroglial cells in rat cerebellum. II. An in situ immunohistochemical study o f oligodendroglial lineage from precursor to mature myelinating cell. Development 102, 409-425. R
ic h a r d s o n ,
W . D ., P
r in g l e ,
N ., M
osley,
M . J ., W
esterm ark ,
B.
and
(1988). A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53, 309-319. R i c h a r d s o n , W . D., R a f f , M. C. a n d N o b l e , M. (1990). The oligodendrocyte-type-2 astrocyte lineage. Semin. Neurosci. 2, 445-454. S a n e t o , R . P. a n d D e v e l l i s , J . (1985). Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined medium. Proc. natn. Acad. Sci. U.S.A. 82, 3509-3513. S a s a h a r a , M., F r i e s , J . W. U., R a i n e s , E. W., G o w n , A . M., W e s t r u m , L. E., F r o s c h , M. P., B o n t h r o n , D. T ., R o s s , R . a n d C o l l i n s , T . (1991). PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell 64, 217—227. S c h Ol e r , H . R. (1991). Octamania: the POU factors in murine development. Trends Genet. 7, 323-329. S m a l l , R . K . , R i d d l e , P. a n d N o b l e , M. (1987). Evidence for migration o f oligodendrocyte-type-2 astrocyte progenitor cells into the developing rat optic nerve. Nature 328, 155-157. S m i t s , A . , K a t o , M . , W e s t e r m a r k , B . , N i s t 6 r , M ., H e l d i n , C.-H. a n d F u n a , K . (1991). Neurotrophic activity of PDGF: rat neuronal cells possess functional PDGF /3-receptors and respond to PDGF. Proc. natn. Acad. Sci. U.S.A. 88, 8159-8163. S o m m e r , I. a n d S c h a c h n e r , M. (1981). Monoclonal antibodies (01 to 04 ) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Devi Biol. 83, 311-327. S u z u k i , N ., R o h d e w o h l d , H., N e u m a n , T., G r u s s , P. a n d S c h Ol e r , H. R. (1990). Oct-6, a POU transcription factor expressed in embryonal stem cells and in the developing brain. EMBO J. 9, 3723-3732. T e m p l e , S. a n d R a f f , M. C. (1985). Differentiation of a bipotential glial progenitor cell in single cell microculture. Nature 313, 223-225. T r a p p , B . D., B e r n i e r , L., A n d r e w s , S . B . a n d C o l m a n , D. R. (1988). Cellular and subcellular distribution of 2 ',3 '-cyclic nucleotide 3'phosphodiesterase and its mRNA in the rat central nervous system. J. Neurochem. 51, 859-868. W a n a k a , A., J o h n s o n , E. M . , J r a n d M i l b r a n d t , J . (1990). Localization o f FGF receptor mRNA in the adult rat central nervous system by in situ hybridization. Neuron 5, 267-281. Yeh, H.-J., Ruit, K . G., W a n g , Y.-X., P a r k s , W . C., S n i d e r , W . D. a n d D eu el, T. F. (1991). PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell 64, 209-216. D
u b o i s -D a l c q ,
M.
P D G F and oligodendrocyte development
123
